Biotechnology Assets, S.A. (BIOTECHNOLOGY ASSETS, S.A.) aksje

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administered as DNA vaccines; and CLICK'N CUT, a tool to obtain tag-less proteins in a one-step process based on intein affinity, as well as Zebrafish assays. The company is based in Cádiz, Spain.